FMP

FMP

Enter

SEER - Seer, Inc.

Financial Summary of Seer, Inc.(SEER), Seer, Inc., a life sciences company, engages in developing and commercializing products to decode th

photo-url-https://financialmodelingprep.com/image-stock/SEER.png

Seer, Inc.

SEER

NASDAQ

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

1.75 USD

0.06 (3.43%)

About

ceo

Dr. Omid C. Farokhzad M.D., Ph.D.

sector

Healthcare

industry

Biotechnology

website

https://seer.bio

exchange

NASDAQ

Description

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk ...

CIK

0001726445

ISIN

US81578P1066

CUSIP

81578P106

Address

3800 Bridge Parkway

Phone

650 453 0000

Country

US

Employee

147

IPO Date

Dec 4, 2020

Summary

CIK

0001726445

Exchange

NASDAQ

Industry

Biotechnology

Sector

Healthcare

CUSIP

81578P106

ISIN

US81578P1066

Country

US

Price

1.75

Beta

1.65

Volume Avg.

460.65k

Market Cap

113.35M

Shares

-

52-Week

1.455-5.65

DCF

0

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-1.3

P/B

-

Website

https://seer.bio

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest SEER News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep